Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07430059

Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant

Conditions: Obesity & Overweight

Sex: All

Ages: 18 Years – 60 Years

Healthy volunteers: No

Phase: PHASE1

Enrollment: 20

Sponsor: Vivani Medical, Inc

Summary

The study will evaluate the safety, tolerability and drug levels of a semaglutide implant placed just under the skin for a period of 4 weeks compared to 4 weekly injections of semaglutide (Wegovy) in overweight/obese participants who are otherwise healthy..

Eligibility Criteria

Inclusion Criteria: * BMI between 27 and 40 kg/m2 (inclusive) * HbA1c \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07430059). StuddyBuddy aggregates publicly available trial information.